Srishti Mishra

Srishti Mishra

Yong Loo Lin School of Medicine, National University of Singapore, Singapore

Title: The potential molecular targets of Fangchinoline for cancer therapy


Srishti Mishra has completed Genetic Engineering degree from SRM University, Chennai, India. She is a Research Assistant in the Department of Pharmacology at National University of Singapore and she has published 4 papers in reputed journals and has been engaged in mentoring the students in their research projects.



Fangchinoline, a traditional Chinese medicine, is a bis-benzylisoquinoline alkaloid isolated from the dried root of Stephaniae tetrandrine S. Moore (family-Menispermaceae). It has been extensively used as an analgesic, anti-rheumatic and anti-hypertensive drug, possesses profound pharmacological activities and has gained a lot of interest due to its anti-cancer activity.